The ICC introduces two IgM MGUS entities, namely plasma cell type and NOS (Table 1).27 The WHO-HAEM5 introduces two subtypes of LPL, namely IgM-LPL type (95% of cases) and non-LPL type (5% of cases). This evidence concerns the gene CD40LG and intrahepatic cholangiocarcinoma.